Results 211 to 220 of about 81,987 (278)

Neck cellulitis complicating spectacle frames' contact dermatitis: A case report. [PDF]

open access: yesSAGE Open Med Case Rep
Hamdan R   +5 more
europepmc   +1 more source

Plastics in dermatology: A review and solutions

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review explores the environmental and health impacts of plastics, particularly microplastics in dermatological products. It discusses the plastic life cycle, routes of exposure, health risks and provides science‐based recommendations to reduce plastic use in dermatology.
Eugene Tan, Susanne Saha, Dennis Niebel
wiley   +1 more source

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A post hoc analysis of Severity of Alopecia Tool (SALT) score trajectories in patients with alopecia areata who received ritlecitinib 50 mg once‐daily in ALLEGRO‐2b/3 and rolled over into the ongoing, open‐label, Phase 3 ALLEGRO‐LT study. Long‐term response patterns up to Month 24 and variables associated with treatment response are described. Abstract
B. King   +15 more
wiley   +1 more source

ARHGAP25: a novel player in the Pathomechanism of allergic contact hypersensitivity. [PDF]

open access: yesFront Immunol
Czárán D   +5 more
europepmc   +1 more source

Completed suicide in patients with skin disease: A systematic review and meta‐analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Several skin diseases have been associated with suicidality. However, the term ‘suicidality’ encompasses ideation, which weakens the conclusions. In contrast, the much stronger endpoint of completed suicide and skin disease remains ambiguous. This was the focus of this study.
B. Hrvatin Stancic   +5 more
wiley   +1 more source

Eyelid Contact Dermatitis: 25-Year Single-Center Retrospective Study. [PDF]

open access: yesJ Clin Med
Rubegni G   +9 more
europepmc   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy